[18F]fibronstatin

氟[18F]纤抑素

Report date: 2025/09/08 17:55:44

NME

Base Information

Drug Name[18F]fibronstatin

Drug Alias Name18F-NOTA-FAPI18F-LNC1005LNC-1005

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionFibroblast activation protein alpha modulators

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsDiagnostic agentsSolid tumoursStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesYantai Lannacheng Biotechnology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYantai Lannacheng Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsDiagnostic agentsSolid tumoursStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A